Rodman & Renshaw Starts Hemab Therapeutics Holdings (COAG) at Buy Oct 12, 2026 07:31AM
Hemab Therapeutics adds Keli Walbert to its board of directors Sep 24, 2026 04:01PM
Hemab Therapeutics Holdings (COAG) PT Raised to $60 at H.C. Wainwright Aug 12, 2026 07:25AM
Hemab Therapeutics Holdings (COAG) PT Raised to $52 at H.C. Wainwright Jul 13, 2026 06:40AM
Hemab shares clinical data on HMB-002, unveils HMB-003 program Jul 13, 2026 05:44AM


Jun 17, 2026 05:59AM H.C. Wainwright Starts Hemab Therapeutics Holdings (COAG) at Buy
May 30, 2026 10:00PM This name is poised to transform care in rare bleeding disorders
May 26, 2026 07:01AM Wedbush Starts Hemab Therapeutics Holdings (COAG) at Outperform
May 26, 2026 03:16AM Jefferies Starts Hemab Therapeutics Holdings (COAG) at Buy
May 26, 2026 12:52AM Goldman Sachs Starts Hemab Therapeutics Holdings (COAG) at Buy
May 1, 2026 09:57AM Hemab Therapeutics indicating open at $21, IPO priced at $18
Apr 27, 2026 07:13AM Hemab Therapeutics Holdings (COAG) files for 11.76M share IPO at $16-$18/sh